Potential effects of curcumin in the treatment of COVID‐19 infection

F Zahedipour, SA Hosseini, T Sathyapalan… - Phytotherapy …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) outbreak is an ongoing pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with considerable …

[HTML][HTML] Ferroptosis and its role in cardiomyopathy

D Li, W Pi, Z Sun, X Liu, J Jiang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Heart disease is the leading cause of death worldwide. Cardiomyopathy is a disease
characterized by the heart muscle damage, resulting heart in a structurally and functionally …

Biomarkers for the adverse effects on respiratory system health associated with atmospheric particulate matter exposure

C Guo, S Lv, Y Liu, Y Li - Journal of Hazardous Materials, 2022 - Elsevier
Large amounts of epidemiological evidence have confirmed the atmospheric particulate
matter (PM 2.5) exposure was positively correlated with the morbidity and mortality of …

Regulation of transforming growth factor-β1–driven lung fibrosis by galectin-3

AC MacKinnon, MA Gibbons, SL Farnworth… - American journal of …, 2012 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a chronic dysregulated response to alveolar
epithelial injury with differentiation of epithelial cells and fibroblasts into matrix-secreting …

Molecular and cellular mechanisms of pulmonary fibrosis

NW Todd, IG Luzina, SP Atamas - Fibrogenesis & tissue repair, 2012 - Springer
Pulmonary fibrosis is a chronic lung disease characterized by excessive accumulation of
extracellular matrix (ECM) and remodeling of the lung architecture. Idiopathic pulmonary …

IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis

E Hams, ME Armstrong, JL Barlow… - Proceedings of the …, 2014 - National Acad Sciences
Disease conditions associated with pulmonary fibrosis are progressive and have a poor
long-term prognosis with irreversible changes in airway architecture leading to marked …

[HTML][HTML] Pulmonary fibrosis: pathogenesis, etiology and regulation

MS Wilson, TA Wynn - Mucosal immunology, 2009 - Elsevier
Pulmonary fibrosis and architectural remodeling of tissues can severely disrupt lung
function, often with fatal consequences. The etiology of pulmonary fibrotic diseases is varied …

TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling

G Epstein Shochet, E Brook, B Bardenstein-Wald… - Respiratory …, 2020 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal disease
characterized by a progressive decline in lung function. Fibrotic diseases, such as IPF, are …

Chitosan-caseinate-dextran ternary complex nanoparticles for potential oral delivery of astaxanthin with significantly improved bioactivity

Q Hu, S Hu, E Fleming, JY Lee, Y Luo - International journal of biological …, 2020 - Elsevier
Astaxanthin (ASTX) has been reported as a potential therapeutic agent for hepatic fibrosis
treatment. However, its therapeutic effect is limited due to low bioavailability and poor …

[HTML][HTML] Cellular and molecular mechanisms of intestinal fibrosis

S Speca, I Giusti, F Rieder, G Latella - World journal of …, 2012 - ncbi.nlm.nih.gov
Fibrosis is a chronic and progressive process characterized by an excessive accumulation
of extracellular matrix (ECM) leading to stiffening and/or scarring of the involved tissue …